89 related articles for article (PubMed ID: 15134300)
21. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
22. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[TBL] [Abstract][Full Text] [Related]
23. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
24. GHRH and GH secretagogues: clinical perspectives and safety.
Aimaretti G; Baldelli R; Corneli G; Bellone S; Rovere S; Croce C; Ragazzoni F; Giordano R; Arvat E; Bona G; Ghigo E
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():86-92. PubMed ID: 16456487
[TBL] [Abstract][Full Text] [Related]
25. Child-onset growth hormone deficiency in adulthood. Transfer of patients from pediatric to adult endocrinology units.
Albero R; Trincado P; Sanz A; Playán J; Acha J
J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():485-94. PubMed ID: 15134312
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
27. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
Trollmann R; Bakker B; Lundberg M; Doerr HG
Pediatr Rehabil; 2006; 9(2):144-8. PubMed ID: 16449073
[TBL] [Abstract][Full Text] [Related]
28. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
Westphal O; Lindberg A;
Acta Paediatr; 2008 Dec; 97(12):1698-706. PubMed ID: 18976357
[TBL] [Abstract][Full Text] [Related]
29. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
Arends NJ; Boonstra VH; Hokken-Koelega AC
Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
[TBL] [Abstract][Full Text] [Related]
30. The impact of fasting and treatment omission on susceptibility to hypoglycaemia in children and adolescents with GH and cortisol insufficiency.
Johnstone HC; McNally RJ; Cheetham TD
Clin Endocrinol (Oxf); 2008 Sep; 69(3):436-42. PubMed ID: 18248651
[TBL] [Abstract][Full Text] [Related]
31. Use of recombinant human growth hormone in children with thalassemia.
Geffner ME; Karlsson H
Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
[TBL] [Abstract][Full Text] [Related]
33. Isolated growth hormone deficiency: clinical entity?
Bianchi A; Giampietro A; Pontecorvi A; De Marinis L
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):12-5. PubMed ID: 19020379
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone treatment of idiopathic short stature: clinical studies.
Hintz RL
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S6-8. PubMed ID: 16039887
[TBL] [Abstract][Full Text] [Related]
35. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
[TBL] [Abstract][Full Text] [Related]
36. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
Hilczer M; Smyczynska J; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
[TBL] [Abstract][Full Text] [Related]
37. Current prescribing practices and opinions about growth hormone therapy: results of a nationwide survey of paediatric endocrinologists.
Hardin DS; Woo J; Butsch R; Huett B
Clin Endocrinol (Oxf); 2007 Jan; 66(1):85-94. PubMed ID: 17201806
[TBL] [Abstract][Full Text] [Related]
38. Effect of GH treatment on bone mass in children with GH deficiency.
Baroncelli GI; Saggese G
J Endocrinol Invest; 2005; 28(10 Suppl):23-7. PubMed ID: 16550718
[TBL] [Abstract][Full Text] [Related]
39. Short stature and metabolic abnormalities in two sisters with a 7.6-kb GH1 gene deletion.
Ahmad T; Geffner M; Parks J; Brown M; Fisher L; Costin G
Growth Horm IGF Res; 2011 Feb; 21(1):37-43. PubMed ID: 21232999
[TBL] [Abstract][Full Text] [Related]
40. Transition from pediatric to adult care for growth hormone deficiency.
Rosenfeld RG
J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():645-9. PubMed ID: 12795367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
